
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: A phase 4 trial
Author(s) -
Ana Cristina Medeiros-Ribeiro,
Nádia Emi Aikawa,
Carla G. S. Saad,
Emily Figueiredo Neves Yuki,
Tatiana do Nascimento Pedrosa,
Solange R. G. Fusco,
Priscila T. Rojo,
Rosa Maria Rodrigues Pereira,
Samuel Katsuyuki Shinjo,
Danieli Andrade,
Percival Degrava Sampaio-Barros,
Carolina Torres Ribeiro,
Giordano B H Deveza,
Vanessa Martins,
Clóvis A. Silva,
Marta Heloísa Lopes,
Alberto J. S. Duarte,
Leila Antonângelo,
Ester C. Sabino,
Esper G. Kallás,
Sandra Gofinet Pasoto,
Eloísa Bonfá
Publication year - 2021
Publication title -
sbr 2021 congresso brasileiro de reumatologia
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2021.1852
Subject(s) - immunogenicity , medicine , immunology , virology , antibody